Natriumklorid-Glucos Viaflo Baxter (Sodium Chloride, Glucose Monohydrate)

Sodium chloride supplies essential sodium and chloride ions that expand extracellular fluid volume and restore osmotic balance. Glucose monohydrate is quickly metabolized by cells, generating ATP and raising blood glucose levels, which supports metabolic functions during fluid loss or hypoglycemic events.

The prescribed dose is determined by the treating physician based on the patient’s fluid status, electrolyte levels, and clinical condition. Dosage is individualized and administered intravenously under medical supervision.

Safety data for use in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any potential risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Compared with plain saline solutions, Natriumklorid-Glucos Viaflo Baxter adds glucose, offering both fluid and energy replacement. This dual action can be advantageous in patients who need rapid correction of hypovolemia and concurrent glucose support, whereas standard saline lacks the carbohydrate component.

The product should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Maintain the cold‑chain during transport and keep the vial in its original packaging until use.

The solution is administered intravenously, typically via a peripheral or central line. Administration rate and volume are determined by the clinician based on the patient’s clinical status, and infusion should be performed under aseptic conditions.

Serious risks include severe allergic reactions (anaphylaxis), fluid overload leading to pulmonary edema, and significant electrolyte disturbances such as hypernatremia or hyperchloremia. Prompt monitoring during and after infusion helps mitigate these risks.

Patients with known hypersensitivity to sodium chloride, glucose monohydrate, or any excipients in the formulation should avoid this product. Additionally, individuals with uncontrolled heart failure, severe renal impairment, or conditions predisposing them to fluid overload require careful evaluation before use.